Sm‐p80–Based DNA Vaccine Provides Baboons with Levels of Protection againstSchistosomamansoniInfection Comparable to Those Achieved by the Irradiated Cercarial Vaccine
Open Access
- 1 April 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (7) , 1105-1112
Abstract
To date, no vaccine is available to prevent human schistosomiasis. We have targeted a protein of Schistosoma mansoni that plays an important role in tKeywords
This publication has 41 references indexed in Scilit:
- Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate modelVaccine, 2009
- Sm‐p80‐based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoniParasite Immunology, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?PLOS Neglected Tropical Diseases, 2008
- Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis ControlPLOS Neglected Tropical Diseases, 2008
- Experimental vaccines in animal models for schistosomiasisParasitology Research, 2008
- Current Status of Vaccines for SchistosomiasisClinical Microbiology Reviews, 2008
- Control of Neglected Tropical DiseasesNew England Journal of Medicine, 2007
- Previous or Ongoing Schistosome Infections Do Not Compromise the Efficacy of the Attenuated Cercaria VaccineInfection and Immunity, 2006
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006